Allergy Therapeutics Plc (AGY) Ord GBP0.01
0.05p
(0.63%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.05p
(0.63%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.05p
(0.63%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
8.00p
8.00p
8.00p
£381.32 million
7.95p
7.25p
3.88p
n/a
0.65p (8.90%) Previous:
0.65p
584,082
n/a
150,000
Performance
| 1 week 1W | 13.57% | 1 year 1Y | 51.72% |
|---|---|---|---|
| 1 month 1M | 11.97% | 2 years 2Y | 657.14% |
| 3 months 3M | 22.69% | 3 years 3Y | 61.69% |
| 6 months 6M | 16.91% | 5 years 5Y | 43.21% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 30/06/2024 | 30/06/2023 |
|---|---|---|
| Revenue (£m) | 55.20 | 59.59 |
| Profit before tax (£m) | (39.17) | (41.77) |
| Adjusted EPS (p): | (1.07) | (6.43) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Allergy Therapeutics starts dosing peanut allergy vaccine candidate
27 March 2023 15:16
-
Allergy Therapeutics confident in funding as results remain late
20 January 2023 12:33
-
Allergy Therapeutics pauses production at Freeman facility
4 October 2022 14:10
-
Allergy Therapeutics presents findings at EAACI
13 June 2025 07:00
-
EAACI Early Career Research Award
10 June 2025 07:04
-
Interim Results for six months ended 31 Dec 2024
31 March 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.